Alvotech and Advanz Pharma Secure EC Approval for Gobivaz®, the First Simponi® (golimumab) Biosimilar in Europe

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

November 21, 2025 | Friday | News
Oncolytics Biotech Gains FDA Agreement on Pivotal Study Design for Pelareorep in First-Line Metastatic Pancreatic Cancer

Company to launch only current registration trial with an immunotherapy in first-line pancreatic cancer in first half of 2026 Trial design allows flex...

November 20, 2025 | Thursday | News
Thermo Fisher Scientific Enrolls First Patient in New PPD™ CorEvitas™ Myasthenia Gravis Registry

  Thermo Fisher Scientific Inc., the world leader in serving science, announced the enrollment of the first patient in the new PPD™ CorEvitas&t...

November 18, 2025 | Tuesday | News
Sarepta Announces Prescribing Information Update for ELEVIDYS Gene Therapy

Sarepta Therapeutics, Inc. the leader in precision genetic medicine for rare diseases,  announced an update to the prescribing information for ELEVI...

November 17, 2025 | Monday | News
Amneal Earns FDA Approval for First Generic Iohexol, Targeting $652M U.S. Market

Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FD...

November 17, 2025 | Monday | News
March Biosciences Receives FDA RMAT Designation for MB-105 CAR-T in T-Cell Lymphoma

- March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers,  announced that the U.S...

November 12, 2025 | Wednesday | News
LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis

 LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical company, announced the initiation of patient dosing in a global Phase 2 cl...

November 11, 2025 | Tuesday | News
Armata Pharmaceuticals Commissions State-of-the-Art cGMP Manufacturing Facility in Los Angeles

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high...

November 11, 2025 | Tuesday | News
Boehringer Ingelheim Receives FDA National Priority Voucher for HERNEXEOS® in First-Line HER2-Mutant NSCLC

  The U.S. Food & Drug Administration (FDA) has awarded a Commissioner's National Priority Voucher (CNPV) for HERNEXEOS® (zongertinib tablets...

November 10, 2025 | Monday | News
Alvotech and Advanz Pharma Receive UK Marketing Authorisations for Gobivaz®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

November 07, 2025 | Friday | News
Clearmind Medicine Files Patent in South Korea for MEAI in Depression Treatment

Patent expands MEAI’s global intellectual property protection as Clearmind advances clinical development and commercialization plans Clearmind Med...

November 06, 2025 | Thursday | News
Pfizer Files Lawsuit Against Metsera and Novo Nordisk Over Breach of Merger Agreement

Pfizer Inc. announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery...

November 03, 2025 | Monday | News
Moleculin Biotech Expands Global IP Protection With New Australian Patent for Novel Annamycin Formulation

Moleculin Biotech, Inc., a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infecti...

November 03, 2025 | Monday | News
Cryoport Sets New Industry Benchmark as First Supply Chain Solutions Provider Certified Under ISO 21973

First Global Supply Chain Solutions Company to Achieve ISO 21973 Certification, Ensuring Highest Transport Safety, Traceability, and Integrity Standards ...

October 31, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close